<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01434706</url>
  </required_header>
  <id_info>
    <org_study_id>10-1414</org_study_id>
    <nct_id>NCT01434706</nct_id>
  </id_info>
  <brief_title>Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection</brief_title>
  <official_title>NAT: The Early Test Program: Implementation of NAT Screening to Identify Acute and Early HIV Infection at San Diego Public HIV Counseling and Testing Sites</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centers for Disease Control and Prevention</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose to study the impact of nucleic acid amplification testing (NAT)
      screening for acute Human Immunodeficiency Virus (HIV) and Hepatitis C (HCV) infections and
      Less-Sensitive Enzyme linked Immunoassay (LS-EIA) or 'detuned' testing Vironostika, Trinity
      Biotech BED, or Ortho-Clinical Diagnostic Vistros ECi for early HIV infection in conjunction
      with routine rapid HIV testing at HIV counseling and testing sites and venues in the San
      Diego county. The overarching goal of this study is to develop and implement a system to
      identify, notify and engage into care those individuals with recent HIV infection in order to
      better define the HIV and Hepatitis C Virus (HCV) epidemics in the San Diego county and to
      evaluate and characterize HIV transmission dynamics within the San Diego population.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2006</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nucleic Acid Amplification Testing</measure>
    <time_frame>10 minutes</time_frame>
    <description>Positive detection of presence of HIV</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12000</enrollment>
  <condition>Acute HIV Infection</condition>
  <arm_group>
    <arm_group_label>Nucleic Acid Amplification Testing</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Nucleic Acid Amplification Testing</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nucleic Acid Amplification Testing</intervention_name>
    <description>The Gen-Probe Transcription-Mediated Amplification (TMA) technology exponentially amplifies captured HIV-1 and HCV RNA in blood samples. The Gen-Probe system is available in two commercially available FDA approved products; 1) the Procleix assay is a multiplex system that is used to screen the blood supply for HIV and HCV. This assay will allow the simultaneous detection of all known HIV-1 subtypes with sensitivities designed to reduce the window period of false negative results from standard HIV antibody testing (EIA), while maintaining the ability to discriminate positive from negative specimens, even at very low copy numbers (Giachetti, Linnen et al., 2002).</description>
    <arm_group_label>Nucleic Acid Amplification Testing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Persons presenting for HIV testing to Public Health Department HIV testing site.

          -  Men and women &gt;13 years of age.

          -  Those who are 13 or older and younger than 18 should be an emancipated minor or have
             consent given by their legal representative.

          -  Participants 18 and over must be able to provide written consent.

          -  Participants should be available for follow up for a period of at least 2 weeks after
             enrollment

        Exclusion Criteria:

          -  Refusal to participate.

          -  Unable to provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>David Rodriguez, BA</last_name>
    <phone>619-543-8130</phone>
    <email>dar002@ucsd.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jill Kunkel, RN</last_name>
    <phone>619-543-3094</phone>
    <email>jkunkel@ucsd.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Christie's Place</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Rodriguez, BA</last_name>
      <phone>619-543-8130</phone>
      <email>dar002@ucsd.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jill Kunkel, RN</last_name>
      <phone>619-543-3094</phone>
      <email>jkunkel@ucsd.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Davey Smith, MD, MAS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Diego LGBT Community Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Rodriguez, BA</last_name>
      <phone>619-543-8130</phone>
      <email>dar02@ucsd.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jill Kunkel, RN</last_name>
      <phone>619-543-3094</phone>
      <email>jkunkel@ucsd.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Davey Smith, MD, MAS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UC San Diego Antiviral Research Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Rodriguez, BA</last_name>
      <phone>619-543-8130</phone>
      <email>dar02@ucsd.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jill Kunkel, RN</last_name>
      <phone>619-543-3094</phone>
      <email>jkunkel@ucsd.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Davey Smith, MD, MAS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCSD Lead the Way Storefront</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Rodriguez, BA</last_name>
      <phone>619-543-8130</phone>
      <email>dar02@ucsd.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jill Kunkel, RN</last_name>
      <phone>619-543-3094</phone>
      <email>jkunkel@ucsd.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Davey Smith, MD, MAS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Family Health Centers of San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Rodriguez, BA</last_name>
      <phone>619-543-8130</phone>
      <email>dar002@ucsd.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jill Kunkel, RN</last_name>
      <phone>619-543-3094</phone>
      <email>jkunkel@ucsd.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Davey Smith, MD, MAS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://theearlytest.ucsd.edu/</url>
    <description>The Early Test</description>
  </link>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2011</study_first_submitted>
  <study_first_submitted_qc>September 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2011</study_first_posted>
  <last_update_submitted>December 2, 2014</last_update_submitted>
  <last_update_submitted_qc>December 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Davey Smith, MD, MAS</investigator_full_name>
    <investigator_title>Professor of Medicinie</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>acute infection</keyword>
  <keyword>primary infection</keyword>
  <keyword>seroconverters</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

